STAND. COM. REP. NO. 1941-24

Honolulu, Hawaii

, 2024

RE: S.C.R. No. 81

S.D. 1

H.D. 1

Honorable Scott K. Saiki

Speaker, House of Representatives

Thirty-Second State Legislature

Regular Session of 2024

State of Hawaii

Sir:

Your Committee on Finance, to which was referred S.C.R. No. 81, S.D. 1, H.D. 1, entitled:

"SENATE CONCURRENT RESOLUTION URGING THE GOVERNOR TO ENSURE THAT RELEVANT STATE AGENCIES, INCLUDING THE DEPARTMENT OF HEALTH AND DEPARTMENT OF HUMAN SERVICES, COLLABORATE TO EXPLORE AVENUES TO ENSURE CONTINUED ACCESS TO AFFORDABLE MEDICATIONS FOR THE STATE'S UNDERSERVED POPULATIONS UNDER THE 340B DRUG PRICING PROGRAM AND URGING HAWAII'S CONGRESSIONAL DELEGATION AND RELEVANT FEDERAL AGENCIES TO MONITOR PHARMACEUTICAL COMPANIES AND TAKE APPROPRIATE ACTIONS TO PROTECT THE INTEGRITY OF THE 340B DRUG PRICING PROGRAM,"

begs leave to report as follows:

The purpose of this measure is to urge the Governor to ensure that relevant state agencies, including the Department of Health and Department of Human Services, collaborate to explore avenues to ensure continued access to affordable medications for the State’s underserved populations under the 340B drug pricing program and urging Hawaii’s congressional delegation and relevant federal agencies to monitor pharmaceutical companies and take appropriate actions to protect the integrity of the 340B drug pricing program.

As affirmed by the record of votes of the members of your Committee on Finance that is attached to this report, your Committee concurs with the intent and purpose of S.C.R. No. 81, S.D. 1, H.D. 1, and recommends its adoption.

Respectfully submitted on behalf of the members of the Committee on Finance,

____________________________

KYLE T. YAMASHITA, Chair